| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-11-15 |
4 |
AS |
$73.10 |
$615,495 |
D/D |
(8,400) |
387,244 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2006-11-09 |
4 |
OE |
$10.38 |
$311,400 |
D/D |
30,000 |
390,399 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-03-01 |
4 |
S |
$132.50 |
$164,300 |
D/D |
(1,240) |
390,670 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-12-17 |
4 |
AS |
$73.90 |
$598,042 |
D/D |
(8,090) |
390,854 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-02-28 |
4 |
S |
$131.71 |
$360,622 |
D/D |
(2,738) |
391,910 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2007-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
393,324 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-02-09 |
4 |
S |
$126.84 |
$31,203 |
D/D |
(246) |
394,648 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-02-07 |
4 |
S |
$128.09 |
$129,371 |
D/D |
(1,010) |
394,894 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-11-15 |
4 |
OE |
$9.00 |
$108,000 |
D/D |
12,000 |
395,644 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-02-06 |
4 |
S |
$125.69 |
$969,728 |
D/D |
(7,715) |
395,904 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-12-17 |
4 |
OE |
$74.00 |
$22,200 |
D/D |
300 |
398,344 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-12-17 |
4 |
OE |
$9.00 |
$108,000 |
D/D |
12,000 |
399,244 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2006-11-14 |
4 |
OE |
$10.38 |
$311,400 |
D/D |
30,000 |
400,674 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2008-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
400,854 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-03-26 |
4 |
OE |
$10.38 |
$311,400 |
D/D |
30,000 |
403,224 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-09 |
4 |
AS |
$144.90 |
$48,397 |
I/I |
(334) |
403,285 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-05 |
4 |
AS |
$134.90 |
$91,783 |
I/I |
(668) |
403,619 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-09 |
4 |
AS |
$144.93 |
$703,345 |
D/D |
(4,853) |
403,619 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-10 |
4 |
AS |
$144.99 |
$14,499 |
D/D |
(100) |
403,619 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-10 |
4 |
OE |
$22.90 |
$2,290 |
D/D |
100 |
403,719 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2008-02-12 |
4 |
AS |
$70.01 |
$601,386 |
D/D |
(8,590) |
404,264 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-11-04 |
4 |
AS |
$139.90 |
$95,123 |
I/I |
(668) |
404,287 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-11-04 |
4 |
AS |
$136.00 |
$5,143,377 |
D/D |
(36,649) |
404,287 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-05 |
4 |
AS |
$135.07 |
$4,704,730 |
D/D |
(34,210) |
404,287 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-10-31 |
4 |
AS |
$135.37 |
$45,214 |
I/I |
(334) |
404,955 |
0 |
- |
|
283 Records found
|
|
Page 3 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
